Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Prior Sodium-Glucose Co-Transporter 2 Inhibitor Use on the Development and Progression of Sepsis-Associated Acute Kidney Injury

NCT06902493 is registered in ClinicalTrials.gov with University of Jazan as lead sponsor.

NCT NCT06902493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06902493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Prior Sodium-Glucose Co-Transporter 2 Inhibitor Use on the Development and Progression of Sepsis-Associated Acute Kidney Injury
Lead sponsor
University of Jazan
Phase
Observational
Overall status
Completed
Start date
April 1, 2024
Completion date
March 1, 2025
Enrollment
664 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, sepsis, septic shock